GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (STU:LO3A) » Definitions » Total Equity

Lonza Group (STU:LO3A) Total Equity : €9,785 Mil (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lonza Group Total Equity?

Lonza Group's total equity for the quarter that ended in Jun. 2024 was €9,785 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Lonza Group Total Equity Historical Data

The historical data trend for Lonza Group's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Total Equity Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,013.13 6,369.48 9,439.04 10,806.96 10,086.15

Lonza Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,834.42 10,806.96 10,630.29 10,086.15 9,784.75

Lonza Group Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Lonza Group's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=17864.958-7778.807
=10,086

Lonza Group's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=18588.315-8803.569
=9,785

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lonza Group Total Equity Related Terms

Thank you for viewing the detailed overview of Lonza Group's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lonza Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (STU:LO3A) » Definitions » Total Equity
Comparable Companies
XSWX:BARN XSWX:EMMN XSWX:ARYN XSWX:ORON XSWX:BELL XSWX:GMI TMO DHR IQV A IDXX MTD ILMN SHSE:603259 WAT LH ICLR DGX NTRA RVTY
Traded in Other Exchanges
LZAGY:USA LZAGF:USA LONN:Mexico LONNz:UK 0QNO:UK LONNE:Switzerland LONN:Switzerland
Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Website
https://www.lonza.com
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group Headlines

No Headlines